MLH1 gene
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (25)
Papers in which this entity is mentioned.
- Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types. (2026)
- Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients (2023)
- Heritable defects in telomere and mitotic function selectively predispose to sarcomas. (2023)
- Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers. (2023)
- Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. (2022)
- Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology. (2021)
- Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. (2021)
- Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
- Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. (2019)
- Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. (2019)
- Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. (2018)
- Comprehensive Characterization of Cancer Driver Genes and Mutations. (2018)
- Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. (2018)
- Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations. (2018)
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. (2017)
- Comprehensive Analysis of Hypermutation in Human Cancer. (2017)
- New insights into the generation and role of de novo mutations in health and disease. (2016)
- DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. (2016)
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
- Integrative clinical genomics of advanced prostate cancer. (2015)
- Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks. (2014)
- Exon identity crisis: disease-causing mutations that disrupt the splicing code. (2014)
- Cancer genome landscapes. (2013)
- Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. (2009)
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. (2008)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| mlh1 | gene | 29 | 55 |